Chronic Endometritis and Benefits of Antibiotics in Women With Recurrent Miscarriage
Recruiting now
Conditions studied: Recurrent Miscarriage
In brief
The aim of the study is to estimate the incidence of CE, evaluate the endometrial microorganism of CE, and investigate the therapeutic benefits of antibiotics for women with unexplained recurrent miscarriage and CE.
Key facts
- Study ID
- NCT06163092
- Run by
- Chinese University of Hong Kong
- People needed
- 175
- Starts
- 2024-04-01
- Expected to finish
- 2027-01-31
- Last updated by the study team
- 2025-03-20
Who can join
Age: 20 and older, up to 45. Sex: female. Healthy volunteers: not accepted.
You may qualify if…
- Women with a history of 2 or more consecutive miscarriages before 24 weeks of gestation
- Women aged 20-45 years old
You may not qualify if…
- Uncorrected uterine anomalies, such as the septate or bicornuate uterus, fibroids (submucous/intramural)
- Untreated hydrosalpinx
- Antiphospholipid syndrome
- Known clinical autoimmune disease
- Undergoing immunotherapy
- Abnormal thyroid function
- Abnormal karyotyping of couples
- Known immunodeficiency pathologies such as diabetes or HIV
- Currently taking other antibiotics or other trial medications or TCM;
- Currently or previously involved in other clinical trials with medication intake;
- Those with active pelvic inflammatory disease or suspicion of infection etc.
Where it is running
- The Chinese University of Hong Kong — Hong Kong, Hong Kong (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.